Ocular Therapeutix announces public offering of common stock
Ocular Therapeutix announced it has commenced a registered underwritten public offering of $25 million of shares of its common stock pursuant to a shelf registration statement previously filed with and declared effective by the SEC. All of the shares in the offering are to be sold by the Company. January 23, 2017